From the discovery of RNAi in process C. Elegans until step in proving the principle to be applied both in vitro and in vivo, and the discovery that siRNA can induce RNAi process. therefore, in the present taking siRNA. (Clinical trial), most of which are in phase 1 and 2, but there are some academic study in phase 3, however, what are the obstacles to development in order to bring applied siRNA to disease in humans, is to develop a delivery system stability. Which is expected in the future as an important alternative to siRNA methods, one of which is used to treat disease in humans with high efficiency.
การแปล กรุณารอสักครู่..